Eucrisa (Anacor Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Eucrisa drug offered from Anacor Pharmaceuticals, Inc.. This Phosphodiesterase 4 Inhibitor [EPC],Phosphodiesterase 4 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Anacor Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | crisaborole |
SUBSTANCE NAME: | CRISABOROLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Phosphodiesterase 4 Inhibitor [EPC],Phosphodiesterase 4 Inhibitors [MoA] |
ROUTE: | TOPICAL |
DOSAGE FORM: | OINTMENT |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-01-30 |
END MARKETING DATE: | 0000-00-00 |
Eucrisa HUMAN PRESCRIPTION DRUG Details:
Item Description | Eucrisa from Anacor Pharmaceuticals, Inc. |
LABELER NAME: | Anacor Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/g) |
START MARKETING DATE: | 2017-01-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55724-211_1a822edc-ab94-4351-8dc9-314d40ee6e83 |
PRODUCT NDC: | 55724-211 |
APPLICATION NUMBER: | NDA207695 |
Other CRISABOROLE Pharmaceutical Manufacturers / Labelers: